Global Bioenergies SA (EPA:ALGBE)
France
· Delayed Price · Currency is EUR 1.172
-0.068 (-5.48%)
Apr 1, 2025, 2:28 PM CET
Global Bioenergies Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 0.36 | 3.25 | 0.7 | 0.1 | 0.06 | Upgrade
|
| Other Revenue | - | - | - | 0.73 | - | Upgrade
|
| Revenue | 0.36 | 3.25 | 0.7 | 0.83 | 0.06 | Upgrade
|
| Revenue Growth (YoY) | -88.90% | 365.83% | -16.15% | 1202.98% | -45.65% | Upgrade
|
| Cost of Revenue | 0.85 | 3.62 | -0.95 | 0.92 | 0.1 | Upgrade
|
| Gross Profit | -0.49 | -0.37 | 1.65 | -0.09 | -0.03 | Upgrade
|
| Selling, General & Admin | 7.77 | 10.69 | 13.79 | 14 | 12.9 | Upgrade
|
| Other Operating Expenses | -4.28 | -5.6 | -0.96 | -3 | -3.16 | Upgrade
|
| Operating Expenses | 6.26 | 9.34 | 14.84 | 13.26 | 13.26 | Upgrade
|
| Operating Income | -6.74 | -9.71 | -13.19 | -13.35 | -13.29 | Upgrade
|
| Interest Expense | -0.3 | -0.12 | -0.12 | -0.11 | -0.2 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0 | -0 | -0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.34 | 0.23 | 0.01 | 0.01 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -6.71 | -9.6 | -13.31 | -13.45 | -13.5 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.03 | -0 | 0.03 | -0.03 | 0.02 | Upgrade
|
| Other Unusual Items | -0.43 | -0.24 | -0.15 | -0 | 0.07 | Upgrade
|
| Pretax Income | -7.11 | -9.84 | -13.43 | -13.48 | -13.41 | Upgrade
|
| Income Tax Expense | -1.25 | -1.19 | -1.45 | -1.71 | -2.26 | Upgrade
|
| Net Income | -5.86 | -8.66 | -11.99 | -11.77 | -11.15 | Upgrade
|
| Net Income to Common | -5.86 | -8.66 | -11.99 | -11.77 | -11.15 | Upgrade
|
| Shares Outstanding (Basic) | 18 | 18 | 15 | 15 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 18 | 15 | 15 | 10 | Upgrade
|
| Shares Change (YoY) | 1.56% | 20.36% | 0.54% | 47.08% | 16.24% | Upgrade
|
| EPS (Basic) | -0.32 | -0.48 | -0.80 | -0.79 | -1.10 | Upgrade
|
| EPS (Diluted) | -0.32 | -0.48 | -0.80 | -0.79 | -1.10 | Upgrade
|
| Free Cash Flow | -7.97 | -8.23 | -12.1 | -14.72 | -11.29 | Upgrade
|
| Free Cash Flow Per Share | -0.43 | -0.46 | -0.81 | -0.99 | -1.11 | Upgrade
|
| Gross Margin | -135.45% | -11.44% | 236.49% | -11.06% | -54.73% | Upgrade
|
| Operating Margin | -1869.85% | -298.87% | -1891.18% | -1604.50% | -20823.10% | Upgrade
|
| Profit Margin | -1625.06% | -266.41% | -1718.39% | -1415.19% | -17461.05% | Upgrade
|
| Free Cash Flow Margin | -2210.34% | -253.13% | -1734.85% | -1769.65% | -17683.01% | Upgrade
|
| EBITDA | -4.24 | -8.19 | -12.45 | -11.99 | -10.02 | Upgrade
|
| EBITDA Margin | - | -252.03% | - | - | - | Upgrade
|
| D&A For EBITDA | 2.5 | 1.52 | 0.74 | 1.35 | 3.28 | Upgrade
|
| EBIT | -6.74 | -9.71 | -13.19 | -13.35 | -13.29 | Upgrade
|
| EBIT Margin | - | -298.87% | - | - | - | Upgrade
|
| Revenue as Reported | 4.69 | 8.91 | 1.71 | 3.88 | 3.28 | Upgrade
|
| Advertising Expenses | 0.06 | 0.15 | 0.31 | 1.29 | 0.03 | Upgrade
|
Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.